A pharmaceutical company has acquired the assets of one of the UK’s largest pharmacy chains, which had become embroiled in a scandal over allegations of corruption.
According to reports, Pharmacy Benefits Group, which includes several Roers pharmacy chains in the UK, acquired the brands of its parent company in February and plans to use the money to improve its customer service.
It has also been reported that the company’s head of operations in the US, Richard Williams, was on the company board.
Williams left Roers in February 2017 amid allegations of widespread bribery and fraud in the pharmaceutical industry, and was recently named a whistleblower by the US Department of Justice.
The acquisition is part of a wider deal between the UK and US for the company to sell its drugs business.
Pharmacy Benefits has a market value of about £4.5bn.